MUCUS RELIEF IMMEDIATE RELEASE- guaifenesin tablet 
Allegiant Health

----------

370 - Health A2Z Mucus Relief

Active ingredient

Guaifenesin 400mg

Purpose

Expectorant

Uses

Warnings

Ask a doctor before use if you have

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
  • cough accompanied by excessive phlegm (mucus)

When using this product

  • do not exceed recommended dosage
  • do not use for more than 7 days

Stop use and ask a doctor if

  • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

Pregnancy/Breastfeeding

ask a health professional before use.

Keep out of reach of children

In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

Adults and children 12 years of age and older: take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 doses in 24 hours.

Children under 12 years of age: do not use

Other information

Inactive ingredients

Croscarmellose Sodium, Maltodextrin, Microcrystalline Cellulose, Povidone, Silicon Dioxide, Stearic Acid

Questions or comments?

Call 1-888-952-0050

Monday through Friday 9AM - PM EST.

Principal Display Panel

Mucus Relief

Mucus Relief

MUCUS RELIEF  IMMEDIATE RELEASE
guaifenesin tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69168-370
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
POVIDONE (UNII: FZ989GH94E)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeROUNDSize17mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69168-370-01100 in 1 BOTTLE; Type 0: Not a Combination Product12/23/2014
2NDC:69168-370-301 in 1 CARTON12/23/2014
230 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:69168-370-411 in 1 CARTON12/23/2014
315 in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:69168-370-17300 in 1 BOTTLE; Type 0: Not a Combination Product03/28/2019
5NDC:69168-370-6060 in 1 BOTTLE; Type 0: Not a Combination Product06/08/2022
6NDC:69168-370-02150 in 1 BOTTLE; Type 0: Not a Combination Product11/06/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01212/23/2014
Labeler - Allegiant Health (079501930)

Revised: 3/2019
Document Id: e6dbafa2-0868-44ec-b764-f15b26a97fce
Set id: 221d64a2-b8c7-435a-aae4-fb58fd38108f
Version: 5
Effective Time: 20190326
 
Allegiant Health